Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.constronicsinfra.com | |
Market Cap | 10.31 Cr. | |
Enterprise Value(EV) | 11.01 Cr. | 2023-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.06 | Trailing Twelve Months Ending 2023-09 |
Price-Earning Ratio (PE) | 224.11 | Trailing Twelve Months Ending 2023-09 |
Industry PE | 63.07 | Trailing Twelve Months Ending 2023-09 |
Book Value / Share | 0.39 | Trailing Twelve Months Ending 2023-09 |
Price to Book Value | 36.49 | Calculated using Price: 14.30 |
Dividend Yield | 0.00 | Period Ending 2023-03 |
No. of Shares Subscribed | 0.72 Cr. | 7,209,041 Shares |
FaceValue | 10 | |
About Constronics Infra Ltd. | ||
Invicta Meditek Limited (Invicta) incorporated in 1992 is a Public Limited company engaged in the manufacture of quality Orthopaedic Implants and Instruments. |
1 Day |
|
|
1 Week |
|
|
1 Month |
|
+24.35% |
3 Month |
|
+19.17% |
6 Month |
|
+147.83% |
1 Year |
|
+135.58% |
2 Year |
|
+55.60% |
5 Year |
|
+209.52% |
10 Year |
|
+123.44% |
9 years | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | 2023-03 | |
Return on Equity (%) | -10.77 | -12.17 | -14.42 | -42.43 | -171.88 | 192.41 | -138.79 | 167.27 | 25.70 | |
Return on Capital Employed (%) | -10.74 | -12.13 | -14.10 | -20.15 | -2.97 | 11.11 | -9.14 | 11.22 | 9.94 | |
Return on Assets (%) | -5.95 | -6.02 | -6.25 | -11.92 | -2.40 | 8.89 | -8.66 | 17.40 | 5.29 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09* Rs. Cr. |
Shh. Funds | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Non Curr. Liab. | 1 | 0 | 0 | 1 | 1 | 1 | 1 | ||||
Curr. Liab. | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | |
Minority Int. | |||||||||||
Equity & Liab. | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Non Curr. Assets | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | |
Curr. Assets | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Particulars | 10 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. | 2023-09 Rs. Cr. TTM |
Net Sales | 1 | 2 | 2 | 2 | 1 | 0 | |||||
Other Income | 0 | 0 | 0 | 0 | 0 | ||||||
Total Income | 0 | 1 | 2 | 2 | 2 | 1 | 1 | ||||
Total Expenditure | 0 | 0 | 0 | 0 | -1 | -2 | -2 | -2 | -1 | 0 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Interest | 0 | 0 | 0 | ||||||||
Depreciation | 0 | 0 | 0 | ||||||||
Taxation | 0 | 0 | 0 | ||||||||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Cash Fr. Inv. | 0 | 1 | |||||||||
Cash Fr. Finan. | 0 | 0 | 0 | 0 | 0 | ||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 1 |
Mon, 27 Nov 2023
Financial Results Along With Limited Review Report As On 30.09.2023 As per the observation made on 24.11.2023 on the financial results for the quarter ended 30.09.2023. we herewith submitting the standalone financials along with the Limited Review Report for your records. |
Fri, 10 Nov 2023
Result For The Period Ended 30.09.2023 We herewith submit the unaudited financial results along with limited review report for the Quarter and half year ended 30.09.2023 |
Fri, 10 Nov 2023
Board Meeting Outcome for Outcome Of The Board Meeting Held On 10.11.2023 We wish to inform you that the board of directors at their meeting held on 10.11.2023 (today) approved the following subject:1. Approval of the unaudited financial statement for the quarter and half year ended 30th September 2023.2. Reviewed on the non-compliance against SDD disclosure.3. other subjects specified in the agenda. |
Thu, 07 Dec 2023 |
|
|
|
|
|